Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes
Authors Guo X, Ding Q, Liang M
Received 23 December 2020
Accepted for publication 3 March 2021
Published 30 March 2021 Volume 2021:14 Pages 1431—1443
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Juei-Tang Cheng
Xintong Guo,1 Qinpei Ding,1 Min Liang2
1Guangxi Medical University, Nanning, Guangxi Province, People’s Republic of China; 2Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, People’s Republic of China
Correspondence: Min Liang
Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of China
Email [email protected]
Purpose: Several previous reports have highlighted the association between adiposity and risk of metabolic syndrome (MetS). Although it is necessary to identify which adiposity indices are best suited to identify MetS, no such study has been completed in diabetic patients. The aim of this study was to evaluate the ability of eight anthropometric indices to identify MetS in diabetic, middle-aged and elderly Chinese patients.
Patients and Methods: A cross-sectional study was conducted in 906 type 2 diabetic patients in Guangxi.
Results: The highest odds ratios for the identification of MetS were identified with CUN-BAE (OR = 28.306). The largest areas under the curve (AUCs) were observed for WHtR and BRI in men aged 40– 59; CUN-BAE in men aged 60 and over; WHtR, BRI, and TyG in women aged 40– 59; and BMI for women aged 60 and over. The weakest indicator for the screening of MetS in type 2 diabetes was the ABSI.
Conclusion: The most effective anthropometric indicator for the identification of MetS varied across sex and age subgroups.
Keywords: metabolic syndrome, anthropometric indices, diabetes
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]